221 related articles for article (PubMed ID: 19396436)
1. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.
Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH
Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436
[TBL] [Abstract][Full Text] [Related]
2. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
3. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.
Arbouw ME; Movig KL; Egberts TC; Poels PJ; van Vugt JP; Wessels JA; van der Straaten RJ; Neef C; Guchelaar HJ
Eur J Clin Pharmacol; 2009 Dec; 65(12):1245-51. PubMed ID: 19669131
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
6. Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence.
Ragia G; Veresies I; Veresie L; Veresies K; Manolopoulos VG
Drug Metab Pers Ther; 2016 Sep; 31(3):143-50. PubMed ID: 27447243
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Krishnamoorthy S; Rajan R; Banerjee M; Kumar H; Sarma G; Krishnan S; Sarma S; Kishore A
Parkinsonism Relat Disord; 2016 Sep; 30():13-7. PubMed ID: 27325396
[TBL] [Abstract][Full Text] [Related]
8. Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy.
Zhang R; Li J; Wu Y; Liang S; Xu L
Genet Test Mol Biomarkers; 2021 Jan; 25(1):20-30. PubMed ID: 33372861
[No Abstract] [Full Text] [Related]
9. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
[TBL] [Abstract][Full Text] [Related]
10. Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.
Rieck M; Schumacher-Schuh AF; Altmann V; Callegari-Jacques SM; Rieder CRM; Hutz MH
Pharmacogenomics J; 2018 Jan; 18(1):196-200. PubMed ID: 27779245
[TBL] [Abstract][Full Text] [Related]
11. Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease.
McDonell KE; van Wouwe NC; Harrison MB; Wylie SA; Claassen DO
Brain Behav; 2018 Jul; 8(7):e01008. PubMed ID: 29856137
[TBL] [Abstract][Full Text] [Related]
12. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.
Hassan A; Heckman MG; Ahlskog JE; Wszolek ZK; Serie DJ; Uitti RJ; van Gerpen JA; Okun MS; Rayaprolu S; Ross OA
Parkinsonism Relat Disord; 2016 Jan; 22():102-5. PubMed ID: 26627941
[TBL] [Abstract][Full Text] [Related]
13. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.
Utsunomiya K; Shinkai T; De Luca V; Hwang R; Sakata S; Fukunaka Y; Chen HI; Ohmori O; Nakamura J
Neurosci Lett; 2008 Oct; 444(2):161-5. PubMed ID: 18703116
[TBL] [Abstract][Full Text] [Related]
14. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.
Makoff AJ; Graham JM; Arranz MJ; Forsyth J; Li T; Aitchison KJ; Shaikh S; Grünewald RA
Pharmacogenetics; 2000 Feb; 10(1):43-8. PubMed ID: 10739171
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole regulates depression-like behavior via dopamine D3 receptor in a mouse model of Parkinson's disease.
Wei SZ; Yao XY; Wang CT; Dong AQ; Li D; Zhang YT; Ren C; Zhang JB; Mao CJ; Wang F; Liu CF
Brain Res Bull; 2021 Dec; 177():363-372. PubMed ID: 34699917
[TBL] [Abstract][Full Text] [Related]
16. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.
Wiesbeck GA; Dürsteler-MacFarland KM; Wurst FM; Walter M; Petitjean S; Müller S; Wodarz N; Böning J
Addict Biol; 2006 Mar; 11(1):72-5. PubMed ID: 16759339
[TBL] [Abstract][Full Text] [Related]
17. DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents.
Bombin I; Arango C; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; Gonzalez-Gomez C; Moreno D; Parellada M; Baeza I; Graell M; Otero S; Saiz PA; Patiño-Garcia A
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):873-9. PubMed ID: 18351593
[TBL] [Abstract][Full Text] [Related]
18. Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations.
Utsunomiya K; Shinkai T; Sakata S; Yamada K; Chen HI; De Luca V; Hwang R; Ohmori O; Nakamura J
Neurosci Lett; 2012 Jan; 507(1):52-6. PubMed ID: 22172931
[TBL] [Abstract][Full Text] [Related]
19. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
[TBL] [Abstract][Full Text] [Related]
20. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
